Data / Form D filings / Galera Therapeutics, Inc.
Galera Therapeutics, Inc.: Form D filings
Galera Therapeutics, Inc., a pharmaceuticals company in Malvern, PA, filed 7 Form D notices with the SEC between 2012 and 2025. The latest, on January 14, 2025, reports $2.9 million sold of a $2.9 million offering to 8 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 45 Liberty Boulevard, Suite 230, Malvern, PA, 19355
- Phone
- (612) 725-1500
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1563577
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 14, 2025 | New notice | $2,885,000 | $2,885,000 | 8 | Dec 30, 2024 | sec.gov | |
| Jan 13, 2025 | New notice | $2,738,355 | $2,738,355 | 18 | Dec 30, 2024 | sec.gov | |
| Sep 17, 2018 | New notice | $70,185,418 | $70,185,418 | 23 | Aug 30, 2018 | sec.gov | |
| Nov 28, 2016 | New notice | $15,000,000 | $15,000,000 | 1 | Nov 15, 2016 | sec.gov | |
| Oct 14, 2015 | New notice | $37,102,500 | $37,102,500 | 7 | Oct 1, 2015 | sec.gov | |
| Aug 6, 2014 | New notice | $9,480,000 | $4,740,000 | $4,740,000 | 7 | Jul 28, 2014 | sec.gov |
| Dec 10, 2012 | New notice | $11,000,000 | $11,000,000 | 4 | Nov 26, 2012 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Nancy T. Chang | Director | |
| J. Mel Sorensen | Executive Officer, Director | |
| Kevin R. Lokay | Director | |
| Michael R. Friedman | Director | |
| Lawrence Mel Alleva | Director | |
| Joel Mel Sussman | Executive Officer |
Other pharmaceuticals companies in Pennsylvania that filed recently
- Telemachus Therapeutics, Inc. $375,000 · Oct 28, 2026
- EpiVario Inc. $185,000 · Oct 13, 2026
- Maxona Pharmaceuticals, Inc. $5.8 million · Aug 14, 2026
- PLEOPHARMA, INC. $5.5 million · Aug 10, 2026
- Duo Oncology Inc. $1.6 million · Aug 7, 2026
Every Form D from the week of Jan 13, 2025 · All recent filings in Pennsylvania · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Galera Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.